This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

2B3-201

BBB Therapeutics B.V.

Drug Names(s): Glutathione PEGylated Liposomal Methylprednisolone

Description: 2B3-201, a glutathione PEGylated liposomal methylprednisolone, acts on neuroinflammation through the Company's proprietary G-Technology delivery system.

Deal Structure: In September 2014, to-BBB announced significant additions to complete its new management team as well as changing its name from to-BBB technologies B.V. to BBB Therapeutics B.V.

2B3-201 News

Pink Sheet Consumer Health Weekly Trademark Review Aug. 8, 2017

Pink Sheet Consumer Health Weekly Trademark Review Aug. 1, 2017

Pink Sheet Consumer Health Weekly Trademark Review July 25, 2017

Scrip AbbVie Hopes Imbruvica, Marivet Build Momentum Before Humira Downturn

Additional information available to subscribers only:

Targets
Routes
Catalysts
Designations
Events

Request a Free Demo Subscriber Login Search for another drug